114736-2
Plasmodium sp DNA [Presence] in Specimen by Molgen
Active
Part Descriptions
LP14840-0 Plasmodium sp
A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.
Source: National Library of Medicine, MeSH 2006
LP14840-0 Plasmodium sp
Plasmodium is a genus of parasitic protozoa. Infection by this parasite is known to cause malaria. The genus Plasmodium was discovered in 1885 by Marchiafava and Celli. Currently over 200 species of this genus are recognized and new species continue to be described.
Of over the 200 known species of Plasmodium, at least 10 species infect humans. Other species infect animals, including monkeys, rodents, birds, and reptiles. The parasite always has two hosts in its life cycle: a mosquito vector and a vertebrate host.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Plasmodium sp
LP20149-8 Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness.
Source: NMS labs
LOINC Names Get Info
- Fully-Specified Name
- Plasmodium sp DNA:
PrThr: Pt: {Specimen}: Ord: {Molgen} - Long Common Name
- Plasmodium sp DNA [Presence] in Specimen by Molgen
- Short Name
- Plasmodium DNA Spec Ql
- Display Name
- Plasmodium sp DNA Molgen Ql (Specimen)
- Consumer Name Alpha Get Info
- Plasmodium sp, Specimen
Part Model Get Info
- Component
- Plasmodium sp DNA
LP57493-6
- Analyte
- Plasmodium sp DNA
LP57493-6
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- {Specimen}
LP451871-0
- System Core
- {Specimen}
LP451871-0
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- {Molgen}
LP452305-8
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.83
- Last Updated
- Version 2.83 (ADD)
- Order vs. Observation
- Both
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41640-0 | Plasmodium |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://